NOVARTIS INDIA
|
NOVARTIS INDIA Last 5 Year Cashflow Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹123 Cr | ₹115 Cr | ₹-3.82 Cr | ₹40 Cr | ₹29 Cr |
Adjustment | ₹-57 Cr | ₹-49 Cr | ₹-5.64 Cr | ₹-4.98 Cr | ₹-12 Cr |
Changes In working Capital | ₹9.04 Cr | ₹-24 Cr | ₹67 Cr | ₹-69 Cr | ₹-1.85 Cr |
Cash Flow after changes in Working Capital | ₹75 Cr | ₹42 Cr | ₹57 Cr | ₹-34 Cr | ₹15 Cr |
Cash Flow from Operating Activities | ₹113 Cr | ₹45 Cr | ₹39 Cr | ₹-69 Cr | ₹-23 Cr |
Cash Flow from Investing Activities | ₹33 Cr | ₹-153 Cr | ₹87 Cr | ₹95 Cr | ₹56 Cr |
Cash Flow from Financing Activities | ₹-121 Cr | ₹-30 Cr | ₹-36 Cr | ₹-37 Cr | ₹-41 Cr |
Net Cash Inflow / Outflow | ₹26 Cr | ₹-139 Cr | ₹90 Cr | ₹-11 Cr | ₹-8.64 Cr |
Opening Cash & Cash Equivalents | ₹19 Cr | ₹158 Cr | ₹68 Cr | ₹79 Cr | ₹88 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹45 Cr | ₹19 Cr | ₹158 Cr | ₹68 Cr | ₹79 Cr |
Compare Cashflow Statement of peers of NOVARTIS INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NOVARTIS INDIA | ₹2,526.6 Cr | -4.7% | -7.9% | 53.4% | Stock Analytics | |
ADANI ENTERPRISES | ₹325,502.0 Cr | -1.6% | -6.1% | 26.8% | Stock Analytics | |
REDINGTON | ₹15,162.5 Cr | 2% | 11% | 23% | Stock Analytics | |
MMTC | ₹11,262.0 Cr | -5.3% | -8.8% | 44.9% | Stock Analytics | |
HONASA CONSUMER | ₹8,567.2 Cr | -29.5% | -37.5% | -6.1% | Stock Analytics | |
MSTC | ₹4,347.2 Cr | 3.8% | -11.1% | 40.3% | Stock Analytics |
NOVARTIS INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NOVARTIS INDIA | -4.7% |
-7.9% |
53.4% |
SENSEX | -2.4% |
-4.2% |
19.5% |
You may also like the below Video Courses